AUG 29, 2014 12:00 AM PDT

Losing Sleep Over It

WRITTEN BY: Ilene Schneider
Loss of brain cells that act as a "sleep switch" may help explain why many seniors have trouble falling and staying asleep, a new study suggests.

In Alzheimer's patients, sleep disruption can be especially severe and often results in nighttime confusion and wandering, according to the researchers.

The investigators analyzed data from the Rush Memory and Aging Project, which includes nearly 1,000 people who enrolled at age 65 and are being followed until death, at which point their brains are donated for research.

The results showed that elderly people and Alzheimer's patients have a substantial decline in what are called ventrolateral preoptic neurons, and that loss of these brain cells is associated with sleep problems.

"On average, a person in his 70s has about one hour less sleep per night than a person in his 20s," senior author Dr. Clifford Saper, chairman of neurology at Beth Israel Deaconess Medical Center in Boston, said in a medical center news release.

Sleep loss and fragmented sleep are associated with a number of health issues, including thinking and memory problems, increased blood pressure and vascular disease, and a tendency to develop type 2 diabetes, Saper said. "It now appears that loss of these neurons may be contributing to these various disorders as people age," he noted.

"These findings provide the first evidence that the ventrolateral preoptic nucleus in humans probably plays a key role in causing sleep, and functions in a similar way to other species that have been studied," Saper said.

The loss of these neurons with aging and with Alzheimer's disease may be a reason why older individuals often face sleep disruptions, he added. "These results may, therefore, lead to new methods to diminish sleep problems in the elderly and prevent sleep-deprivation-related cognitive [mental] decline in people with dementia," he concluded.

The study was published online August 20 in the journal Brain. The U.S. National Library of Medicine has more about age related changes in sleep.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAR 20, 2020
Neuroscience
MAR 20, 2020
The Little Things Matter: The Mental Impact of Social Distancing
Image: Metropolitian State University of Denver The COVID-19 pandemic has caused social interactions, resources, and mos ...
MAR 12, 2020
Drug Discovery & Development
MAR 12, 2020
Brain Stimulants Help with Focus
Drugs like Ritalin, Adderall and similar medications have been assumed by the public as fuels to help people focus. But, ...
MAR 24, 2020
Neuroscience
MAR 24, 2020
Researchers Use Silicon to Record Electrical Signals Between Neurons
Researchers from Stanford University have created a way to connect the brain directly to silicon-based technologies. Hop ...
MAR 04, 2020
Neuroscience
MAR 04, 2020
Memories Are Stored As Specific Neural Firing Patterns
Scientists working on the EPFL Blue Brain Project explain the algebraic patterns of neuron activity.  Scientists at ...
MAY 11, 2020
Cell & Molecular Biology
MAY 11, 2020
3D Cell Culture Model Suggests Herpes Can Cause Alzheimer's
Alzheimer's is a common form of dementia that affects as many as 5.5 million Americans and the incidence is increasing a ...
MAY 25, 2020
Genetics & Genomics
MAY 25, 2020
FDA Approves the First Treatment for Neurofibromatosis 1
In a major breakthrough, the Food and Drug Administration has approved a treatment for a genetic disorder called neurofi ...
Loading Comments...